↓ Skip to main content

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medellín, Colombia

Overview of attention for article published in Hereditary Cancer in Clinical Practice, April 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
71 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medellín, Colombia
Published in
Hereditary Cancer in Clinical Practice, April 2014
DOI 10.1186/1897-4287-12-11
Pubmed ID
Authors

Julián Esteban Londoño Hernández, Marcia Llacuachaqui, Gonzalo Vásquez Palacio, Juan David Figueroa, Jorge Madrid, Mauricio Lema, Robert Royer, Song Li, Garrett Larson, Jeffrey N Weitzel, Steven A Narod

Abstract

Approximately 5% of all breast cancers can be attributed to a mutation in the BRCA1 or BRCA2 gene. The genetic component of breast cancer in Colombia has been, for the most part, studied on cases from the Bogota region. Five different founder mutations were in two studies of breast cancer patients in the Bogota region. It is important that the frequency of mutations be established among unselected cases of breast cancer of other regions of Colombia in order to estimate the genetic burden of this cancer in Colombia and to plan genetic services. The aim of this study was to establish the mutation frequencies of the BRCA genes in breast cancer patients unselected for family history or age, from Medellin, Colombia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 1%
Brazil 1 1%
Unknown 69 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 18%
Student > Master 10 14%
Student > Bachelor 10 14%
Student > Ph. D. Student 6 8%
Other 3 4%
Other 11 15%
Unknown 18 25%
Readers by discipline Count As %
Medicine and Dentistry 19 27%
Agricultural and Biological Sciences 17 24%
Biochemistry, Genetics and Molecular Biology 10 14%
Business, Management and Accounting 1 1%
Nursing and Health Professions 1 1%
Other 4 6%
Unknown 19 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2014.
All research outputs
#16,046,765
of 25,373,627 outputs
Outputs from Hereditary Cancer in Clinical Practice
#115
of 260 outputs
Outputs of similar age
#129,532
of 238,626 outputs
Outputs of similar age from Hereditary Cancer in Clinical Practice
#2
of 9 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 260 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,626 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.